Pientzehuang Pharmaceutical revises articles, appoints new board secretary

Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. announced comprehensive revisions to its articles of association, approved by the seventh board of directors at its thirty-sixth meeting on November 19, 2025. These revisions, pending shareholder approval, streamline governance by replacing "shareholders' meeting" with "shareholder assembly," eliminating the supervisory board, and transferring its functions to the board's audit committee. The company will also establish an employee representative director elected by the employee representative assembly and discontinue the board's budget committee.

In a related development, Mr. Shi Yixiong resigned as board secretary due to a work division adjustment, effective November 19, 2025, but will continue as deputy general manager. The board approved the appointment of Mr. He Wei as the new board secretary, with his term coinciding with that of the seventh board of directors. The company also released a revised Investment and Financing Management System, effective November 19, 2025, clarifying procedures for investment and financing decisions, risk management, and accountability, including a pre-approval process by the company's Party Committee for "Major Decisions" items.